While product readiness is often world-class, organisational readiness frequently lags – and that gap can cost millions and hinder their ability to deliver promises made to the market.
50–70% of first-time biotech launches underperform (ZS, McKinsey).
Only 1 in 3 launches meet or exceed expectations (McKinsey).
42% of recent innovative drug launches under performed at six months post-launch (IQVIA).
Common causes include internal misalignment, cross-functional frictions, and limited adoption of digital and AI strategies – not scientific failure (MAPS and BCG).
Even small shifts in human readiness, alignment, mindset and belief, and field execution, can unlock at least 3-6% of commercial value. For a product forecasted at $500M, that’s $15M–$30M in additional value. Investing in your people means investing in Launch Success – unlocking measurable commercial impact and outperforming expectations.
Open Water partners with launch teams to successfully transition from R&D to commercial organisations, reducing human friction and preparing winning mindsets.
→ Shift from R&D mindset to commercial and enterprise mindset
→ Frictionless commercial execution and delivery
→ Unlock commercial value at speed through human readiness
We ensure your people are as ready as your product – aligned, confident, and prepared to go to market – and deliver.
A short self-assessment to help you identify where human execution risk may affect launch momentum, alignment and commercial value.
Take The Launch Pulse Now
From Misalignment to Market Leader: How Open Water Helped Set the Stage for a $13.3B Blockbuster
Read the Case StudyOpen Water’s Connected Partner Program transformed a sales force into trusted advisors, driving a 20% sales uplift for a new psychiatric drug and revitalising stagnant product sales through customer-centric engagement.
Read the Case StudyA new narrative focused on connection to purpose, energises, empowers and refocuses the senior team of a lacklustre immuno-inflammatory business
Read the Case StudyHow Open Water Drove Measurable Sales Impact Across EMEA
Read the Case Study